Curavac Europe SA
Curavac Europe reported total assets of €2.53m at the end of the 2024 financial year (annual accounts filed with the NBB on 04 Jul 2025).
By total assets for 2024, Curavac Europe ranks among the 100 largest of the 338 companies in its sector (NACE 2110) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Curavac Europe shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2024
Change 2021 → 2024: Equity +180 % Total assets +16 %
Accounts of the company itself (not consolidated).
The full file covers 8 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Curavac Europe's annual accounts
Filed annual accounts
- Year ended 31 Dec 2024filed on 04 Jul 2025
- Year ended 31 Dec 2023filed on 14 Jun 2024
- Year ended 31 Dec 2022filed on 13 Jun 2023
- Year ended 30 Sep 2021filed on 11 Mar 2022
- Year ended 30 Sep 2020filed on 26 Feb 2021
Curavac Europe's financial analysis
- Solvency44.9%sector median: 46.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Curavac Europe
Curavac Europe's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0479.403.989
- VAT number
- BE0479403989
- Peppol
- Registered · 0208:0479403989 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 28 Jan 2003
- Registered office
- 1330 Rixensart
- Latest accounts
- 2024 · filed on 04 Jul 2025
- Activity
- Manufacture of basic pharmaceutical products (NACE 21100)
Curavac Europe (SA) has been based in Rixensart since 2003, active in: manufacture of basic pharmaceutical products. For 2024, it reports a net loss of 257,915 € and equity of €1.13m; its revenue is not published. Its solvency stands at 44.9%, below the median of its sector (46.9%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Curavac Europe
Companies in the same business, of comparable size and area, outside its group.
- NeGIO Therapeutics Manufacture of basic pharmaceutical products Charleroi · balance sheet €4.76m
- Verbert Manufacture of pharmaceutical preparations Antwerp · balance sheet €2.70m
- FASE Manufacture of pharmaceutical preparations Nazareth-De Pinte · balance sheet €2.45m
- Société d’Études, Commercialisation et Réalisation Manufacture of basic pharmaceutical products Anderlecht · balance sheet €1.70m
- GRNR Invest Manufacture of basic pharmaceutical products Zemst · balance sheet €2.26m
- Lifrank Manufacture of basic pharmaceutical products Wingene · balance sheet €4.07m
- Pharma Chemicals France Manufacture of basic pharmaceutical products Braine-le-Château · balance sheet €1.08m
- Dr. Ghijsels Erik, Nefroloog Manufacture of basic pharmaceutical products Affligem · balance sheet €1.18m
Frequently asked questions about Curavac Europe
What is the revenue of Curavac Europe?
Curavac Europe files its accounts in a format where revenue is optional: it is not published for 2024.
What is the VAT number of Curavac Europe?
In Belgium, the VAT number is the company number prefixed with BE: BE0479403989 for Curavac Europe, if the company is VAT-registered. Its company number (CBE) is 0479.403.989.
Where is the registered office of Curavac Europe?
According to the CBE register, the registered office of Curavac Europe is in 1330 Rixensart.
What is the equity of Curavac Europe?
At the close of the 2024 financial year, the equity of Curavac Europe amounts to 1,133,250 €, a solvency of 44.9% of total assets.
Who manages Curavac Europe?
The register lists 8 active mandates at Curavac Europe. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Curavac Europe within its sector?
By total assets for 2024, Curavac Europe ranks among the 100 largest of the 338 companies in its sector (NACE 2110) in Belgium that filed accounts for that financial year.
The full file of Curavac Europe
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →